What is Quinidine gluconate?
Quinidine gluconate is the water‑soluble salt form of quinidine, a class IC antiarrhythmic drug used primarily to treat ventricular and supraventricular tachycardia. It is also prescribed for certain malaria parasites and for the prevention of tetanus‑related seizures when combined with tetanus toxoid.
How is it typically given?
The drug is available as an oral solution or a parenteral injection. Oral doses range from 30 mg to 360 mg taken 2–4 times daily, depending on the arrhythmia type and patient factors. Intravenous administration is usually 500–800 mg over 10 minutes for acute arrhythmia control, followed by a maintenance infusion of 250 mg per hour.
What’s the mechanism of action?
Quinidine blocks fast sodium channels in cardiac cells, slowing conduction through the AV node and decreasing the automaticity of ventricular myocardium. The result is a prolongation of the QRS complex and a reduction in the heart’s ectopic firing.
Which side effects do patients report most?
Common adverse events include nausea, vomiting, constipation, dizziness, and a characteristic blue discoloration of the tongue or gums. Severe reactions can involve prolonged QT interval, torsades de pointes, or neurotoxic symptoms like seizures or paresthesias when the drug is overdosed or metabolized slowly.
Who should avoid using it?
Patients with pre‑existing heart block, severe electrolyte disturbances, or significant liver disease should not receive quinidine. Those on drugs that prolong the QT interval (e.g., sotalol, amiodarone) or CYP3A4 inhibitors (e.g., ketoconazole) are at higher risk for toxicity.
What interactions matter?
Quinidine is metabolized by CYP3A4; inhibitors can raise its levels, while inducers (e.g., rifampin) lower them. It also interacts with digoxin, propranolol, and certain antimalarials, potentially altering efficacy or safety.
How does it stack against other antiarrhythmics?
Compared to amiodarone, quinidine is faster‑acting but carries a higher risk of neurotoxicity and a narrower therapeutic index. Unlike class I drugs, it has less impact on atrioventricular conduction at therapeutic doses, making it a preferred option for certain supraventricular tachycardias.
When do its patents expire?
All original quinidine patents, including those covering the gluconate salt, have long since expired. Generic versions are widely available, and the DrugPatentWatch database indicates no active patents protecting the formulation as of the latest update [1].
Where can I obtain it?
Quinidine gluconate is sold under various brand names (e.g., Quinidex, Quinidone) and generic forms in pharmacies and hospital formularies worldwide. Availability may vary by country, so checking local drug registries or consulting a pharmacist is advisable.
Sources
[1] https://drugpatentwatch.com/quinidine (patent status and generic availability)